154 related articles for article (PubMed ID: 38590175)
1. ATP Citrate Lyase is a General Tumour Biomarker and Contributes to the Development of Cutaneous Squamous Cell Carcinoma.
Luo R; Huang Y; Bai R; Liu M; Sun L; Wang X; Zheng Y
Acta Derm Venereol; 2024 Apr; 104():adv23805. PubMed ID: 38590175
[TBL] [Abstract][Full Text] [Related]
2. ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis.
Wang D; Yin L; Wei J; Yang Z; Jiang G
Tumour Biol; 2017 Apr; 39(4):1010428317698338. PubMed ID: 28443474
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer.
Wang Y; Wang Y; Shen L; Pang Y; Qiao Z; Liu P
Oncol Rep; 2012 Apr; 27(4):1156-62. PubMed ID: 22266777
[TBL] [Abstract][Full Text] [Related]
4. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2α/ATF4/CHOP axis.
Zheng Y; Zhou Q; Zhao C; Li J; Yu Z; Zhu Q
J Cell Mol Med; 2021 Feb; 25(3):1468-1479. PubMed ID: 33393219
[TBL] [Abstract][Full Text] [Related]
5. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
Zaidi N; Royaux I; Swinnen JV; Smans K
Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913
[TBL] [Abstract][Full Text] [Related]
6. ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition.
Guo W; Ma J; Yang Y; Guo S; Zhang W; Zhao T; Yi X; Wang H; Wang S; Liu Y; Dai W; Chen X; Shi Q; Wang G; Gao T; Li C
Clin Cancer Res; 2020 Jun; 26(11):2725-2739. PubMed ID: 32034077
[TBL] [Abstract][Full Text] [Related]
7. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.
Pearce NJ; Yates JW; Berkhout TA; Jackson B; Tew D; Boyd H; Camilleri P; Sweeney P; Gribble AD; Shaw A; Groot PH
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):113-9. PubMed ID: 9693110
[TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of a human ATP-citrate lyase cDNA.
Elshourbagy NA; Near JC; Kmetz PJ; Wells TN; Groot PH; Saxty BA; Hughes SA; Franklin M; Gloger IS
Eur J Biochem; 1992 Mar; 204(2):491-9. PubMed ID: 1371749
[TBL] [Abstract][Full Text] [Related]
9. miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.
Xin M; Qiao Z; Li J; Liu J; Song S; Zhao X; Miao P; Tang T; Wang L; Liu W; Yang X; Dai K; Huang G
Oncotarget; 2016 Jul; 7(28):44252-44265. PubMed ID: 27317765
[TBL] [Abstract][Full Text] [Related]
10. Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.
Fan Z; Qin J; Wang D; Geng S
J Cell Mol Med; 2019 May; 23(5):3097-3107. PubMed ID: 30825266
[TBL] [Abstract][Full Text] [Related]
11. ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
Han Q; Chen CA; Yang W; Liang D; Lv HW; Lv GS; Zong QN; Wang HY
Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):251-261. PubMed ID: 33129711
[TBL] [Abstract][Full Text] [Related]
12. Identification of the active site residues in ATP-citrate lyase's carboxy-terminal portion.
Nguyen VH; Singh N; Medina A; Usón I; Fraser ME
Protein Sci; 2019 Oct; 28(10):1840-1849. PubMed ID: 31411782
[TBL] [Abstract][Full Text] [Related]
13. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.
Migita T; Narita T; Nomura K; Miyagi E; Inazuka F; Matsuura M; Ushijima M; Mashima T; Seimiya H; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y
Cancer Res; 2008 Oct; 68(20):8547-54. PubMed ID: 18922930
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
15. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
16. [Expression and Clinical Significance of ATP Citrate Lyase in Hepatocellular Carcinoma].
Yu HJ; Wei LY; Liu SS; Zhang ZT; Guan CJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):743-751. PubMed ID: 37927015
[TBL] [Abstract][Full Text] [Related]
17. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.
Guo L; Guo YY; Li BY; Peng WQ; Chang XX; Gao X; Tang QQ
J Biol Chem; 2019 Aug; 294(31):11805-11816. PubMed ID: 31197036
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth.
Gao Y; Islam MS; Tian J; Lui VW; Xiao D
Cancer Lett; 2014 Jul; 349(1):15-25. PubMed ID: 24690568
[TBL] [Abstract][Full Text] [Related]
19. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact.
Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Taguchi R; Soga T; Seimiya H
Am J Pathol; 2013 May; 182(5):1800-10. PubMed ID: 23506848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]